A real-time fluorogenic polymerase chain reaction (PCR) assay based on SYBR green that allows for sensitive, reproducible, and accurate quantification of Babesia gibsoni (Asian genotype). DNA from peripheral blood of infected dogs was developed. Standard curves were created by plotting the input amount of a standard template, constructed with plasmid DNA containing 182 base pairs (bp) of the p18 gene, against threshold cycle numbers. The curves showed a wide dynamic range (1,000,000-fold input) and high correlation values (Ͼ0.99). The PCR amplification efficacy of the standard template was similar to that of intact genomic DNA obtained from peripheral blood with B. gibsoni infection. The detection limit of the assay was 9 parasites/ l of blood with B gibsoni infection. The intra-assay and interassay coefficients of variation of the threshold cycles ranged from 0.70% to 1.89% and from 1.18% to 1.92%, respectively. This assay system was found to be reproducible and accurate for the quantification of parasite DNA in experimentally infected dogs and far more sensitive than traditional microscopic examination.
and inexpensive diagnostic test, it is, however, of low sensitivity in detecting the parasites when an animal has low parasitemia. Because B. gibsoni is a small, pleomorphic organism, unlike the paired piriform-shaped Babesia canis, 4 a high level of skill is required to distinguish it from artifacts. The polymerase chain reaction (PCR) assay has been widely employed in clinical applications 2, 20 and in some epidemiological studies 15, 19 to detect this parasite in blood taken from host dogs with a high degree of sensitivity. However, the conventional PCR assay does not permit estimation of the initial concentration of target DNA and is only semiquantitative. Therefore, an assay with higher sensitivity and reproducibility is needed to determine the degree of infection with B. gibsoni.
Real-time PCR is a method that can be used to monitor amplicon formation throughout the PCR reaction and to estimate the initial concentration of target DNA in samples. 1 This method has been used to estimate genome numbers and for diagnostic detection of parasites, such as Plasmodium spp. 11, 18 and T. gondii. 5 In this study, a quantitative real-time PCR assay system was developed using a pair of primers specific to the p18 gene of B. gibsoni for quantification of the parasites. These primers are specific for B. gibsoni and appropriate for the conventional PCR. 9 Clinical applications were evaluated using peripheral whole blood obtained from experimentally infected beagle dogs at an early stage of B. gibsoni (Asian genotype) infection.
The use of animals was approved by the University's Animal Care and Ethics Committee. Three 2-year-old female beagle dogs were obtained from a commercial supplier a and maintained in a closed environment in the authors' laboratory for 1 month prior to the study. All dogs received a physical examination and they were all vaccinated against canine distemper and parvovirus. It was ascertained that Babesia spp. were not present in their peripheral blood. All dogs were placed in separate cages and fed on commercial dog feed b according to the manufacturer's instructions and tap water provided ad libitum.
Babesia gibsoni was isolated from a naturally infected Tosa dog in Aomori Prefecture, Japan, in 2003. 16 The 18S rDNA sequences of this parasite shows 100% homology to B. gibsoni isolated from dogs in Asia, Oklahoma, North Carolina, and Okinawa. 12 This is considered to be an Asian genotype of B. gibsoni. It was maintained in our laboratory by passage through a beagle dog (3-year-old, female) in a subclinical condition for 6 months. Babesia gibsoni parasitemia was determined by counting the number of parasitized erythrocytes within 5,000 erythrocytes in thin blood smears stained with Giemsa stain.
For the quantitative detection using real-time PCR, a previously described set of primers targeting the p18 gene (DDBJ databases under the accession number AB053292) was used 9 (forward: 5Ј-TCC GTT CCC ACA ACA CCA GC-3Ј; reverse: 5Ј-TCC TCC TCA TCA TCC TCA TTC G-3Ј). A plasmid clone containing a 182-base pair fragment of the p18 target gene was used as a template for creating standard curves for quantification of parasite DNA in unknown samples. The plasmid was constructed from peripheral blood collected from the subclinically infected dog mentioned previously using a commercial cloning kit. c Sequence analysis of the plasmid insert DNA was performed using a commercial sequencing system d,e and computer program. f Subsequently, 10-fold plasmid DNA serial dilutions were prepared, and the standard curve was created by plotting the log initial copy number of input plasmid DNA against the threshold cycle (Ct) value.
Real-time PCR reaction was performed using a standard protocol recommended by the manufacture. g One microliter of template DNA was added to 24 l of reaction mixture containing dNTP (200 M dATP, dCTP, dGTP and 400 M dUTP), 3 mM MgCl 2 , 50 nM of each primer, 1.25 U AmpliTaq Gold DNA polymerase, and 1 l SYBR green PCR buffer. The mixture was incubated under the following conditions: h 50ЊC for 2 minutes and 95ЊC for 10 minutes as the denaturation program, followed by 40 cycles of 15 seconds of denaturation at 95ЊC and 1 minute of annealing and extension at 60ЊC.
To determine the detection limit of this assay system, genomic DNA was extracted from 10-fold diluted peripheral blood infected with B. gibsoni. The infected blood sample was obtained from a subclinically infected dog with 90,000 parasites/l of blood (1.8% parasitemia, 5,000,000/l red blood cells j ) and was serially diluted 10-fold to 9 parasites/ l of blood with uninfected dog blood. After the genomic DNA was extracted from 100 l of each diluted blood sample using a commercial DNA extraction kit, j 1 l of genomic DNA solution was used as template DNA for real-time PCR. This was carried out in triplicate. The PCR amplification curve was established between Ct values obtained by realtime PCR and initial parasite number/l of blood. Coefficients of variation (CV) were calculated for Ct values to examine the reproducibility of this assay system. The intraassay CV was determined by assaying 5 replicates of diluted samples within a single assay, and the interassay CV was determined by testing identical samples in 5 separate assays.
Three beagle dogs (A, B, and C) were inoculated intra-venously with 50,000,000 B. gibsoni parasites. The infected blood samples were collected at 1-2-day intervals for about 3 weeks to determine parasitemia and packed cell volume (PCV). The blood samples were stored at Ϫ80ЊC until used for real-time PCR assay. Every real-time PCR assay included standard plasmid DNA in a tube separate from that of the test sample. This was used to create standard curves for Ct.
The Ct values derived from clinical samples were compared with standard Ct values, and a copy number was calculated for the p18 gene. The correlation between parasitemia and time after inoculation or the copy number of the p18 gene was examined.
To optimize the conditions for real-time PCR amplification, we tested the effect of various concentrations of MgCl 2 and primers as well as annealing and denaturing temperatures using the manufacturer's protocol. Optimal conditions for this system were established and used for further analysis. The amplified fragment of p18 DNA sequences used in this study showed 100% homology with previously reported sequences of B. gibsoni (AB053292). Standard curves from 6 different experiments showed 1,000,000-fold dynamic range (220-22,000,000 times the initial copy number of plasmid DNA). These curves exhibited similar slopes (Ϫ3.12 Ϯ 0.10; mean Ϯ standard deviation), and the correlation value was 0.99 Ϯ 0.004 within the range tested (Ct: 17.55 Ϯ 0.48 to 32.88 Ϯ 0.48) (Fig. 1A) . The real-time PCR assay could detect the p18 gene from genomic DNA samples extracted from peripheral blood with 90,000 to 9 parasites/ l of whole blood (Ct: 21.99 Ϯ 0.18 to 33.97 Ϯ 0.18). The PCR amplification curves obtained from 3 different experiments exhibited similar slopes (Ϫ3.08 Ϯ 0.09), and the correlation value was 0.99 Ϯ 0.01 within the input range tested (Fig. 1B) . There was no significant difference between the slopes of the PCR amplification curves for plasmid DNA and for genomic DNA extracted from whole blood (F ϭ 1.27, P ϭ 0.99). The intra-assay and interassay CV for Ct values derived from serially diluted samples ranged from 0.70% to 1.89% and from 1.18 to 1.92%, respectively.
The parasite organisms were first detected 3-5 days postinfection; parasitemia was quantified at 9-13 days postinfection by microscopic examination. PCV decreased gradually after inoculation and it was lower than 30% on days 11, 13, and 21 in the 3 dogs. The B. gibsoni p18 gene was first detected by real-time PCR on the day after inoculation. And p18 copy number occurred in all 3 dogs ( Table 1 ). The correlation coefficients of the relationships between times after inoculation and p18 copy number were 0.65 (P ϭ 0.042), 0.619 (P ϭ 0.032), and 0.576 (P ϭ 0.081) in dogs A, B, and C, respectively. The correlation coefficients of the relationships between parasitemia and p18 copy number were 0.942 (P ϭ 0.0000446), 0.729 (P ϭ 0.0072), and 0.527 (P ϭ 0.527) in dogs A, B, and C, respectively.
A real-time PCR assay that allows for sensitive and reproducible quantification of B. gibsoni DNA from the peripheral blood of host dogs was developed using SYBR green. The quantitative assay system was developed using a pair of primers that is specific to the p18 gene of B. gibsoni because there was no amplification when DNA from B. canis or normal dog leukocytes 9 were used. The nucleotide sequences of the PCR products used in this study were iden- tical to those listed in a published database (AB053292). It has been shown that the region of the p18 gene targeted by this set of primers is well conserved in B. gibsoni in Korea. 19 Although the specificity of this primer for B. gibsoni species recently identified in North America and Europe 14 has not been confirmed, it is appropriate for use with the Asian genotype of B. gibsoni.
The lower quantification limit of this assay was 9 parasites/l of peripheral whole blood (Fig. 1B) . The sensitivities of other methods, such as conventional PCR, nested PCR, or loop-mediated isothermal amplification method, are 0.000002% of parasitemia 9 (same primer set as used in the present study), 50 parasites/ml of blood, 3 0.0005% parasitemia, 12 respectively. It has been suggested that it is inappropriate to compare test sensitivities on the basis of parasitemia percentage because of differences between the amounts of RBCs from normal dogs used to dilute infected blood and differences in the degree of anemia of infected dogs. 3 The sensitivity of our assay may be lower than that of nested PCR, 3 but the initial concentration of target DNA in samples used to determine these reported sensitivity values is unknown. Despite this, our study is the first fluorogenic real- 72,000 310,000 620,000 2,900,000 380,000 * Parasitemia was determined by microscopic examination. † p18 copy number was determined by real-time PCR and calculated from standard curve constructed with plasmid DNA on each experiment. ‡ Not detected. § Parasite organism was detected but the number was under 5 parasites of 5,000 counts. time PCR assay for quantitative detection of B. gibsoni DNA. The Ct values for parasite number more than 90,000 parasites/l of whole blood were not examined because the parasitemia of subclinically infected dogs did not develop in this study.
This quantification system for B. gibsoni parasites was based on standard curves constructed from data derived from plasmid DNA. Some real-time PCR assay systems for intraerythrocytic protozoa quantification use infected blood for estimation of initial parasitemia or parasite number. 11, 13 However, direct correlation between parasite numbers estimated from parasitemia in whole blood and the amount of parasite gene may not necessarily be accurate in these systems because the possibility of multiple division of B. gibsoni within 1 erythrocyte has been reported. 6, 8 The plasmid DNA template may be amplified more than genomic DNA because genomic DNA contains many similar sequences that could prevent specific amplification. Therefore, there is a possibility that quantification with genomic DNA will result in underestimation when calculations are based on a plasmid standard curve. However, from our result, a statistical comparison between the curve for amplification efficacy of plasmid DNA and that for genomic DNA as a PCR template showed that there was no significant difference (Fig. 1) . This result demonstrates that this assay system is suitable for quantification of the amount of target p18 DNA in unknown samples using a standard curve.
Because SYBR green fluoresces strongly when bound to double-stranded DNA, the possibility exists that it will bind to nonspecific double-stranded DNA as well as the target. To establish the specificity of this assay, a melting curve analysis was performed using the p18 primer sets, and no primer-dimers or nonspecific amplifications were observed within the range tested (data not shown).
The method developed in this study demonstrated that B. gibsoni DNA was detected and quantified at an early stage of infection, when parasitemia is very low and would be undetectable by microscopic examination. Moreover, an exponential increase of p18 copy number from whole blood was observed. There was no significant correlation between p18 copy number and times or parasitemia for dog C. This may be due to a drastic decrease in parasite numbers during days 17-19 (2,900,000-380,000 parasites/l of whole blood) in spite of an increase in parasitemia. The acute progression of anemia might have induced this phenomenon. In this system, the quantity of parasites present was assessed as p18 copy number/l peripheral whole blood. Thus, when PCV is decreased, the absolute amounts of the gene also decrease.
After the first 3 weeks, the apparent quantity of parasites in blood changed markedly because the experimental dogs developed severe anemia and required blood transfusion. PCV and the quantity of B. gibsoni p18 gene were monitored during weeks 3-17 and during weeks 3-11 in 2 of the experimental dogs. Babesia gibsoni p18 copy number remained at 10,000-100,000 parasites/l blood even though the magnitude of anemia decreased and parasitemia decreased intermittently to levels that could not be detected by microscopic examination (data not shown). These results suggest that this assay could be a useful tool in some applications. For example, the ability to quantify low levels of parasitemia may allow the monitoring of vaccine efficacy at presymptomatic levels and determination of the progression of infection under drug treatment. Moreover, elucidation of the immunological or clinicopathological responses in host dogs at an early stage of infection, which, in the case of canine babesiosis, are currently not yet fully understood.
In conclusion, this assay system offers an accurate, sensitive, and reproducible method for quantification of B. gibsoni DNA in clinical blood samples. The use of this system in clinical trials and laboratory investigations could result in new information on canine B. gibsoni infection.
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